recurrent platinum-sensitive fallopian tube cancer

DBCOND0128089Genital Neoplasms, Female Malignant Neoplasm of Fallopian Tube

recurrent platinum-sensitive fallopian tube cancer is the indication for 1 drug in DrugBank. It is covered by 3 curated, structured indications.

Classified under: Genital Neoplasms, Female
Malignant Neoplasm of Fallopian Tube
Ovarian and fallopian tube cysts and neoplasms
Tubal Obstruction
Indicated drugs: Bevacizumab

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for recurrent platinum-sensitive fallopian tube cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account